US Senate committee advances bill to improve drug-pricing transparency; Wicker questions FTC's 'catch-all hook'
A US Senate committee cleared a bill that would prevent unfair and deceptive practices related to pharmacy benefit-management services for prescription drugs in a 19-9 vote, but not before a Republican...To view the full article, register now.
Already a subscriber? Click here to view full article